Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2025-12-24 @ 11:10 PM
NCT ID:
NCT06710769
Eligibility Criteria:
Inclusion Criteria:
* Newly diagnosed or relapsed malignancy with proposed treatment regimen containing at least ONE (1) of the following:
whole abdomen or pelvic irradiation
total body irradiation
Proposed treatment regimen to include any of the following:
cyclophosphamide equivalent dose (CED, see Green et al 2014) ≥7.5 g/m2
any treatment regimen containing procarbazine
bone marrow transplant conditioning regimen containing alkylators
OR health condition or malignancy that requires removal of one or both ovaries. Health status adequate to undergo elective laparoscopic surgery (as per anesthesiologist assessment)
Exclusion Criteria:
* Pregnancy or a patient who is currently breastfeeding
Patients who are eligible for and agree to oocyte preservation
Anyone deemed high risk for complications from the surgery and/or anesthesia.
Anyone unable to provide consent due to psychiatric conditions or cognitive delay (in parent/guardian for patients \<18 years, and patient \>18 years)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
1 Year
Maximum Age:
25 Years
Study:
NCT06710769
Study Brief:
Protocol Section:
NCT06710769